Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
Authors
Keywords
-
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 385, Issue 4, Pages 337-372
Publisher
Springer Nature
Online
2012-02-13
DOI
10.1007/s00210-012-0734-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular properties affecting fast dissociation from the D2 receptor
- (2011) Gary Tresadern et al. BIOORGANIC & MEDICINAL CHEMISTRY
- P02-314 - Membrane lipid rafts are required for D2 dopamine receptor signaling
- (2011) D. Sibley et al. EUROPEAN PSYCHIATRY
- Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
- (2011) Maria Eklind-Cervenka JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Binding of “AT4 receptor” ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells
- (2011) Heidi Demaegdt et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Anatomically distinct dopamine release during anticipation and experience of peak emotion to music
- (2011) Valorie N Salimpoor et al. NATURE NEUROSCIENCE
- Understanding wiring and volume transmission
- (2010) Luigi F. Agnati et al. BRAIN RESEARCH REVIEWS
- Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays
- (2010) Steven J Charlton et al. BRITISH JOURNAL OF PHARMACOLOGY
- Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a ‘two-step’ competition binding approach
- (2010) A Packeu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action
- (2010) Georges Vauquelin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Presynaptic Dopamine in Schizophrenia
- (2010) Nobumi Miyake et al. CNS Neuroscience & Therapeutics
- All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
- (2010) Philip Seeman CNS Neuroscience & Therapeutics
- P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophrenia
- (2010) M. Schmidt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- P.3.d.009 Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia
- (2010) X. Langlois et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Rebinding: or why drugs may act longerin vivothan expected from theirin vitrotarget residence time
- (2010) Georges Vauquelin Expert Opinion on Drug Discovery
- The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
- (2010) Robert A Copeland Expert Opinion on Drug Discovery
- Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs
- (2010) Rumin Zhang et al. Expert Opinion on Drug Discovery
- Antagonist-D2S-dopamine receptors interactions in intact Chinese recombinant ovary cells
- (2010) Ann Packeu et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Synthesis and Evaluation of a Set of 4-Phenylpiperidines and 4-Phenylpiperazines as D2Receptor Ligands and the Discovery of the Dopaminergic Stabilizer 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine (Huntexil, Pridopidine, ACR16)
- (2010) Fredrik Pettersson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Influence of Phasic and Tonic Dopamine Release on Receptor Activation
- (2010) J. K. Dreyer et al. JOURNAL OF NEUROSCIENCE
- Detection of angiotensin II type 1 receptor ligands by a cell-based assay
- (2009) Matthias Grießner et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Molecular mechanisms for the persistent bronchodilatory effect of the β2-adrenoceptor agonist salmeterol
- (2009) A Szczuka et al. BRITISH JOURNAL OF PHARMACOLOGY
- Incorporating Receptor Theory in Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling
- (2009) Bart A. Ploeger et al. Drug Metabolism and Pharmacokinetics
- Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors
- (2009) Yoshihiro Tadori et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties
- (2009) Tino Dyhring et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Non-competitive interaction between raclopride and spiperone on human D2L-receptors in intact Chinese hamster ovary cells
- (2009) Ann Packeu et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Paracrine Transactivation of the CB1Cannabinoid Receptor by AT1Angiotensin and Other Gq/11Protein-coupled Receptors
- (2009) Gábor Turu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
- (2009) S E Kjeldsen et al. JOURNAL OF HUMAN HYPERTENSION
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- Ligands, their receptors and … plasma membranes
- (2009) G. Vauquelin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
- (2009) Ningning Guo et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2and D3dopamine receptors
- (2009) Mette Skinbjerg et al. SYNAPSE
- Antagonist-radioligand binding to D2L-receptors in intact cells
- (2008) Ann Packeu et al. BIOCHEMICAL PHARMACOLOGY
- Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
- (2008) Peter J. Tummino et al. BIOCHEMISTRY
- Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway
- (2008) Margaret E. Rice et al. BRAIN RESEARCH REVIEWS
- Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding
- (2008) H Demaegdt et al. BRITISH JOURNAL OF PHARMACOLOGY
- Using pharmacokinetic–pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics
- (2008) Christina Kurre Olsen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The role of D1–D2 receptor hetero-dimerization in the mechanism of action of clozapine
- (2008) Agata Faron-Górecka et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Restricted Collision Coupling of the A2AReceptor Revisited
- (2008) Christoforos Charalambous et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride
- (2008) Lawrence S Kegeles et al. NEUROPSYCHOPHARMACOLOGY
- Antagonism of dopamine D2 receptor/ -arrestin 2 interaction is a common property of clinically effective antipsychotics
- (2008) B. Masri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dopamine D2Highreceptors measured ex vivo are elevated in amphetamine-sensitized animals
- (2008) Philip Seeman SYNAPSE
- G Protein–Coupled Receptor Sorting to Endosomes and Lysosomes
- (2007) Adriano Marchese et al. Annual Review of Pharmacology and Toxicology
- Heterotrimeric G protein activation by G-protein-coupled receptors
- (2007) William M. Oldham et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More